The effect of smoking on human papillomavirus (HPV) activity and subsequent dysplasia and neoplasia remains controversial
Objective:
To determine any reported effects of smoking on either HPV activity or HPV-related dysplasia/cancer using retrospective analysis of the literature from 1966 through 1998 via Toxline and PubMed to search for “smoking,” “papillomavirus,” and “cancer.”
Conclusion:
Several recent large studies demonstrated that smoking was associated with a greater incidence of cervical, vulvar, penile, anal, oral, and head and neck cancer in a dose-dependent fashion, while other studies did not show any correlation between smoking and cervical dysplasia after multivariate adjustment. Recent studies have also indicated that smoking may be more closely related to high-grade lesions of the cervix and vulva. These data provide evidence of an association between HPV, smoking, and cancer. Progression of dysplasia likewise seems to be associated with smoking. Several groups have attempted to discern whether the connection between smoking and cervical cancer is from local immunosuppression and/or from direct carcinogenic effects.
Get full access to this article
View all access options for this article.
References
1.
BeutnerKRTyringSK. Human papillomavirus and human disease. Am J Med1997; 102(5A):9–15.
2.
WinkelsteinW. Smoking and cervical cancer—Current status: A review. Am J Epidemiol1990; 131:945–957.
3.
ReevesWCBrintonLABrenesMM. Case control study of cervical study in Herrera Province, Republic of Panama. Int J Cancer1985; 36:55–60.
4.
CelentanoDDKlassenACWeismanCS. The role of contraceptive use in cervical cancer: The Maryland cervical cancer case-control study. Am J Epidemiol1987; 126:592–604.
5.
BohlmeyerTLeTNShroyerAL. Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol1998; 18(2):265–269.
6.
TrofatterKF. Diagnosis of human papillomavirus genital tract infection. Am J Med1997; 102(5A):21–27.
7.
MunkCSvareEIPollP. History of genital warts in 10,838 women 20–29 years of age from the general population. Sex Transm Dis1997; 24(10):567–572.
8.
PalefskyJMMinkoffHKalishLA. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HTV)-positive and high-risk HIV-negative women. J Natl Cancer Inst1999; 91(3):226–236.
9.
FeldmanJGChirgwinKDehovitzJA. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol1997; 89:346–350. DOI: 10.1016/S0029-7844(97)00011-2
10.
HockeCLeroyVMorlatP. Cervical dysplasia and human immunodeficiency virus infection in women: Prevalence and associated factors. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GESCA). Eur J Obstet1998; 81(1):69–76.
11.
DalingJRMadeleineMMMcKnightB. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev1996; 5(7):541–548.
12.
KjaerSKEngholmGDahlC. Case-control study of risk factors for cervical squamous cell neoplasia in Denmark. IV: Role of smoking habits. Eur J Cancer Prev1996; 5(5):359–365.
13.
BurgerMPHollemaHGouwAS. Cigarette smoking and human papillomavirus in patients with reported cytologic abnormality. BMJ1993; 306(6880):749–752.
14.
ChichareonSHerreroRMunozN. Risk factors for cervical cancer in Thailand: A case-control study. J Natl Cancer Inst1998; 90(1):50–57.
15.
NgelangelCMunozNBoschFX. Causes of cervical cancer in the Philippines: A case-control study. J Natl Cancer Inst1998; 90(1):43–49.
16.
YlitaloNSorensenPJosefssonA. Smoking and oral contraceptives as risk factors for cervical carcinoma in situ. Int J Cancer1998; 81(3):357–365.
17.
CuzickJSasieniPSingerA. Risk factors for invasive cervix cancer in young women. J Cancer1996; 32A(5):836–841.
18.
YoshikawaHNagataCNodaK. Human papillomavirus infection and other risk factors for cervical intraepithelial neoplasia in Japan. Br J Cancer1999; 80:621–624.
19.
RezzaGGiulianiMSerrainoD. Risk factors for cervical presence of human papillomavirus DNA among women at risk for HIV infection. DIANAIDS Collaborative Study Group1998; 121(1):173–177.
20.
RemminkAJWalboomersJMHeimerhorstTJ. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Intl J Cancer1995; 61(3):306–311.
21.
BrissonJMorinCFortierM. Risk factors for cervical intraepithelial neoplasia: Differences between low- and high-grade lesions. Am J Epidemiol1994; 140(8):700–710.
22.
HoGYKadishASBurkRD. HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia. Int J Cancer1998; 78(3):281–285.
23.
Roteli-MartinsCMPanettaKAlvesVA. Cigarette smoking and high-risk HPV DNA as predisposing factors for high-grade cervical intraepithelial neoplasia (CIN) in young Brazilian women. Acta Obstet Gynecol Scand1998; 77(6):678–682.
24.
HildesheimAHanCLBrintonLA. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study. Obstet Gynecol1997; 90:748–754. DOI: 10.1016/S0029-7844(97)00467-5
25.
MadeleineMMDalingJRCarterJJ. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst1997; 89:1516–1523. DOI: 10.1093/jnci/89.20.1516
26.
HellbergDValentinJEldundT. Penile cancer: Is there an epidemiological role for smoking and sexual behavior?BMJ1987; 295:1306–1308.
27.
FrischMGlimeliusBWohlfahrtJ. Tobacco smoking as a risk factor in anal carcinoma: An antiestrogenic mechanism?J Natl Cancer Inst1999; 91(8):708–715.
28.
BjoreTHakulinenTEngelandA. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res1997; 57:3989–3992.
29.
SugarJVereczkeyITothJ. Some etio-pathogenetic factors in laryngeal carcinogenesis. Environ Pathol Toxicol Oncol1996; 15:194–199.
30.
FranceschiSTalaminiRBarraS. Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in Northern Italy. Cancer Res1990; 50:6502–6507.
31.
BalaramPNalinakumariKRAbrahamE. Human papillomavirus in 91 oral cancers from India betel quid chewers—high prevalence and multiplicity of infections. Int J Cancer1995; 61:450–454.
32.
FouretPMonceauxGTemanS. Human papillomavirus in head and neck squamous cell carcinomas of nonsmokers. Arch Otolarygol Head Neck Surg1997; 123:513–516.
33.
PortugalLGGoldenbergJDWenigBL. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg1997; 123(11):130–1234.
34.
SchwartzSMDalingJRDoodyDR. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst1998; 90(21):1626–1636.
35.
HirayasuTIwamasaTKamadaY. Human papillomavirus DNA in squamous cell carcinoma of the lung. J Clin Pathol1996; 49(10):810–817.
36.
MaurerTAChristianVin KKerschmannRL. Cutaneous squamous cell carcinoma in human immunodeficiency virus-infected patients. A study of epidemiologic risk factors, human papillomavirus, and p53 expression. Arch Dermatol1997; 133:577–583.
37.
BarrBBMcLarenKSmithIW. Human papillomavirus infection and skin cancer in renal allograft recipients. Lancet1989; 1:124–128.
38.
EvrardSChardonnetYPouteil-NobleC. Association of skin malignancies with various and multiple carcinogenic and non-carcinogenic human papillomaviruses in renal transplant recipients. Cancer1993; 72:2198–2206.
39.
McGregorJMFarthingACrookT. Post-transplant skin cancer: A possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol1994; 26:840–845.
40.
HoGYFBiermanRBeardsleyL. Natural history of cervicovaginal papillomavirus infection in young women. New Engl J Med1998; 338:423–428.
41.
SchneiderAGrubertTKirchmayrR. Efficacy trial of topically administered interferon gamma-lβ gel in comparison to laser treatment in cervical intraepitheial neoplasia. Arch Gynecol Obstet1995; 256:75–83. DOI: 10.1007/S004040050072
42.
SarmaDYangXJinG. Resistance to retinoic acid and altered cytokeratin expression of human papillomavirus type 16-immortalized endocervical cells after tumorigenesis. Int J Cancer1996; 65(3):345–350.
43.
WernessBALevineAJHowleyPM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science1990; 248:76–79.
44.
BrennanJABoyleJOKochWM. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. New Engl J Med1995; 332:712–717.
45.
ProkopczykBCoxJEHoffmannD. Identification of tobacco-specific carcinogen in the cervical mucus of smokers and non-smokers. J Natl Cancer Inst1997; 89(12):868–873.
46.
BartonSEMaddoxPHJenkinsD. Effect of cigarette smoking on cervical epithelial immunity: A mechanism for neoplastic change?Lancet1988; 2:652–654.
47.
MorelliAESananesCDiPG. Relationship between types of human papillomavirus and Langerhans cells in cervical condyloma and intraepithelial neoplasia. Am J Clin Pathol1993; 99:200–206.
48.
MorrisHHBGatterKCSykesG. Langerhans cells in human cervical epithelium: Effects of wart virus infection and intraepithelial neoplasia. Br J Obstet Gynaecol1983; 90:412–420.
49.
PalanPRChangCJMikhailMS. Plasma concentrations of micro-nutrients during a nine-month clinical trial of beta-carotene in women with precursor cervical cancer lesions. Nutr Cancer1998; 30(1):46–52.
50.
SimonsAMPhillipsDHColemanDV. Damage to DNA in cervical epithelium related to smoking tobacco. BMJ1993; 306:1444–1448.
51.
SizemoreNMukhtarHCouchLH. Differential response of normal and HPV immortalized ectocervical epithelial cells to B[a]P. Carcinogenesis1995; 16(10):2413–2418.
52.
CerqueiraEMSantoroCLDonozoNF. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?Acta Cytol1998; 42(3):639–649.
